Catrin Cox

Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive breast cancer (FAKTION): a multicentre, randomised, controlled, phase 2 trial

Robert H. Jones, Angela Casbard, Margherita Carucci et al. · The Lancet Oncology · 2020 · 227 citations · Full text

Medicine, Oncology, Pharmacology +17

Age and frailty are independently associated with increased COVID-19 mortality and increased care needs in survivors: results of an international multi-centre study

Mustafa Alsahab, Lucy Beishon, Bryony Brown et al. · Age and Ageing · 2021 · 170 citations · Full text

Medicine, Geriatric Medicine, Frailty +13

Preservation of ovarian function in young women treated with neoadjuvant chemotherapy for breast cancer: A randomized trial using the GnRH agonist (triptorelin) during chemotherapy

Roohi Ismail‐Khan, S. Minton, Catrin Cox et al. · Journal of Clinical Oncology · 2008 · 53 citations

Medicine, Endocrinology, Oncology +17

Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma

Michelle R. Goulart, Jennifer Watt, Imran Siddiqui et al. · npj Precision Oncology · 2021 · 25 citations · Full text

Medicine, Oncology, Pathology +17

Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trial

Somnath Mukherjee, Ganesh Radhakrishna, Sarah Gwynne et al. · European Journal of Cancer · 2021 · 20 citations · Full text

Medicine, Oncology, Surgery +17